UBS Group’s Chemtura Corporation CHMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-655
Closed -$22K 8380
2017
Q1
$22K Sell
655
-2,260
-78% -$75K ﹤0.01% 6091
2016
Q4
$97K Sell
2,915
-5,437
-65% -$179K ﹤0.01% 5316
2016
Q3
$274K Sell
8,352
-21,445
-72% -$619K ﹤0.01% 4325
2016
Q2
$786K Buy
29,797
+25,021
+524% +$676K ﹤0.01% 3578
2016
Q1
$126K Sell
4,776
-20,429
-81% -$522K ﹤0.01% 4803
2015
Q4
$687K Buy
25,205
+2,325
+10% +$69.2K ﹤0.01% 3699
2015
Q3
$655K Sell
22,880
-3,657
-14% -$100K ﹤0.01% 3685
2015
Q2
$751K Buy
26,537
+1,266
+5% +$37.4K ﹤0.01% 3789
2015
Q1
$690K Buy
25,271
+21,445
+561% +$530K ﹤0.01% 3887
2014
Q4
$94K Buy
+3,826
New +$88.9K ﹤0.01% 5766

UBS Group's CHMT Position: Q2 2017 in Review

UBS Group sold out of Chemtura Corporation (CHMT) in Q2 2017, closing a stake of 655 shares — an estimated $22K sold.

UBS Group first reported a position in CHMT in Q4 2014 and held it in 10 quarters. The position peaked at $786K in Q2 2016. 0 funds tracked by Wall St. Rank hold CHMT as of Q2 2017.

  • UBS Group reported no remaining Chemtura Corporation position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 655 Chemtura Corporation shares in Q2 2017, an estimated $22K.
  • UBS Group first reported a position in Chemtura Corporation in Q4 2014 and held it in 10 quarters.
  • UBS Group's Chemtura Corporation position peaked at $786K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Chemtura Corporation as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.